November 9, 2015
Sanofi’s and Regeneron’s study shows improvements in signs and symptoms of rheumatoid arthritis
Sanofi and Regeneron Inc. have announced results from a pivotal Phase 3 study of sarilumab, an investigational, human antibody against…
